Inventor · disambiguated record
Cyril Clarke
Also filed as: CLARKE CYRIL · CLARKE CYRIL R · CLARKE CYRIL ROY
7 granted patents·1 pending application·110 citations·filing 1989–2020
85Inventor score
Files withMEREO BIOPHARMA 1 LTD3UNIV OKLAHOMA STATE2DEANS ROBERT1OKLAHOMA STATE UNIVERSITY PHYS1REGENTS OKLAHOMA STATE UNIVERS1
Top patents by PatentIndex Score
8 records- 0190US5468858AN-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agentsOKLAHOMA STATE UNIVERSITY PHYS·Filed 1993·Granted Nov 21, 1995·76 cites·5 claims
- 0288US10603306B2Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary diseaseMEREO BIOPHARMA 1 LTD·Filed 2016·Granted Mar 31, 2020·5 cites·20 claims
- 0378US10617674B2Dosage regimen for the treatment of acute exacerbations of inflammatory conditionsMEREO BIOPHARMA 1 LTD·Filed 2016·Granted Apr 14, 2020·4 cites·16 claims
- 0465US5110933ASalts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereofUNIV OKLAHOMA STATE·Filed 1990·Granted May 5, 1992·10 cites·4 claims
- 0562US5084572ASalts of 3-azabicyclo [3.3.1]nonanes as antiarrhythmic agents, and precursors thereofUNIV OKLAHOMA STATE·Filed 1989·Granted Jan 28, 1992·6 cites·11 claims
- 0659US11129810B2Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary diseaseMEREO BIOPHARMA 1 LTD·Filed 2020·Granted Sep 28, 2021·0 cites·16 claims
- 0758US5786481AN-alkyl and N-acyl derivatives of 3,7-Diazabicyclo- 3.3.1!nonanes and selected salts thereof as multi-class antiarrhythmic agentsREGENTS OKLAHOMA STATE UNIVERS·Filed 1995·Granted Jul 28, 1998·9 cites·1 claims
- 0846US2006024707A1Luminescent polymers and methods of use thereofDEANS ROBERT·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cyril Clarke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →